Browse Tag

analyst downgrade

SoFi Technologies (SOFI) Stock Today, November 26, 2025: Analyst Downgrade, Institutional Buying and Crypto Buzz Collide

SoFi Technologies (SOFI) Stock Today, November 26, 2025: Analyst Downgrade, Institutional Buying and Crypto Buzz Collide

SoFi Technologies, Inc. (NASDAQ: SOFI) is trading slightly higher today, November 26, 2025, as investors digest a mix of fresh analyst commentary, new institutional ownership disclosures, and renewed coverage of the company’s crypto ambitions. As of mid-session, SoFi shares are
Exact Sciences (EXAS) Stock Today: Analyst Downgrades, Abbott’s $21 Billion Takeover and Legal Scrutiny – 25 November 2025

Exact Sciences (EXAS) Stock Today: Analyst Downgrades, Abbott’s $21 Billion Takeover and Legal Scrutiny – 25 November 2025

Exact Sciences Corporation (NASDAQ: EXAS) is trading near record highs as Wall Street shifts to “Hold,” merger-arb funds move in and shareholder lawyers start circling Abbott’s $21 billion bid. Exact Sciences Stock Price Snapshot for 25 November 2025 On Tuesday,
Costco Stock Today, November 25, 2025: Valuation Jitters, Downgrade and What’s Next for COST Ahead of Earnings

Costco Stock Today, November 25, 2025: Valuation Jitters, Downgrade and What’s Next for COST Ahead of Earnings

Costco Wholesale Corporation (NASDAQ: COST) heads into Tuesday, November 25, 2025, trading just under the $900 mark after another choppy session, extending a months‑long pullback that has erased its 2025 gains. Recent data show the stock closing around $886 per
Microsoft (MSFT) Stock Outlook (Nov 2025): AI-Powered Growth, Strong Earnings, and 2026 Forecast

Microsoft Stock Today, November 20, 2025: Analyst Downgrades, Bill Gates’ Big Sale and New AI Deals Shape MSFT

Microsoft stock (NASDAQ: MSFT) ended Thursday’s session modestly higher, closing at $491.37, up about 0.9% on the day after trading in a tight range between roughly $490 and $494. Investing.com That bounce comes after a bruising few days in which the stock fell around 5%
Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025

Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025

Repare Therapeutics Inc. (NASDAQ: RPTX) is back in the spotlight today after investors digested last week’s surprise acquisition agreement with XenoTherapeutics, Inc., a Massachusetts-based non‑profit biotech. The stock is trading sharply higher and unusually active as the market prices in
Go toTop